Clinical Research Directory
Browse clinical research sites, groups, and studies.
Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults
Sponsor: Mª Jesús Periago
Summary
The Sulforaphane-Smart® formula is a pill, patented by the company INGREDALIA, prepared with broccoli by-products which have been concentrated and enriched in glucosinolates/isothiocyanates (GLS/ITCs). The goal of this intervention study is to evaluate if the chronic consumption of GSL/ITC (Sulforaphane Smart® formula) could modulate the biomarkers related to chronic inflammation, oxidative stress and gut microbiota in overweight and obese volunteers. In order to reach this goal, the volunteers will take daily the Sulforaphane Smart® formula during 12 weeks (total of 84 days). Anthropometric measurements will be taken and biological samples of blood, urine and feces will be collected at the beginning of the intervention (initial time), after six weeks of the intervention (Time 6 weeks) and at the end of the intervention (Time 12 weeks).
Official title: Sulforaphane-Smart® on Lipid and Glucose Metabolism, Inflammation, Adiposity and Microbiome of Overweight Adults "SANO"
Key Details
Gender
All
Age Range
20 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-07
Completion Date
2026-12
Last Updated
2025-05-09
Healthy Volunteers
No
Conditions
Interventions
Sulforaphan-Smart® formula
Volunteers will intake a daily dose of Sulforaphan-Smart® pill for 12 weeks (84 days)
Control (placebo) group
Volunteers will intake a daily dose of placebo pill for 12 weeks (84 days)
Locations (1)
Edificio Pleyades-Vitalys 5ª y 6ª planta, Campus Universitario, Espinardo
Murcia, Spain, Spain